Two cases of COPD benefitting from therapy with roflumilast

Submitted: August 19, 2015
Accepted: August 19, 2015
Published: August 19, 2015
Abstract Views: 688
PDF: 628
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Two clinical cases of chronic obstructive pulmonary disease (COPD) stage II patients are reported here. One case refers to a patient with hypoxemia associated to severe air flow limitation, chronic bronchitis and frequent exacerbation events. A significant improvement of patient’s conditions was observed after pharmacological treatment with roflumilast. The second case refers to a patient who refused to adhere to prescribed therapy but adhered to roflumilast therapy, eventually achieving a good response. Both cases highlight roflumilast’s efficacy in improving health conditions of COPD patients.



PlumX Metrics


Download data is not yet available.


How to Cite

Carraro, Chiara Francesca. 2015. “Two Cases of COPD Benefitting from Therapy With Roflumilast”. Monaldi Archives for Chest Disease 79 (3-4).